IFPMA Framework for Action on NCDs
Read more
Open-ended meeting of Member States on the follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG) Delivered by Mario Ottiglio, Associate Director, Public Affairs & Global Health Policy Check against Delivery (26 November 2012) Thank you on behalf of the International Federation of Pharmaceutical Manufacturers and Associations...
Read more
Mr. Masafumi Nogimori President and CEO, Astellas Pharma Inc.
Read moreGeneva, October 31, 2012 Panel III: “Societal Partner: Ensuring Innovation Serves Social and Business Needs” Seth Berkley, CEO, GAVI Alliance Caroline Roan, President, Pfizer Foundation Mark Kramer, Co-founder and Managing Director, FSG Group Rogier Snijdewind, Head of Responsible Investing, PGGM
Read moreGeneva, October 31, 2012 Panel II: “Creative Innovation: Addressing Key Research Gaps” Ama de-Graft Aikins, Visiting Fellow, London School of Economics, Health Francis Gurry, Director General, World Intellectual Property Organization Trevor Mundel, President, Global Health Program, Gates Foundation Dhaval D Patel, Head, Novartis Institutes for BioMedical Research Europe, Novartis Bernard Pécoul, Executive Director, Drugs for...
Read moreGeneva, October 31, 2012 Panel I: “Innovation Today: Treading New Ground to Meet Global Health Needs” Cary Adams, CEO, Union for International Cancer Control Nigel Darby, Vice President of Biotechnologies, Chief Technology Officer GE Healthcare David Khayat, Professor and Head of Medical Oncology, Pitié-Salpêtrière Hospital John Lechleiter, Chairman, President, and CEO, Eli Lilly & Company...
Read moreRiz Khan
Read moreWilliam Charnetski, AstraZeneca
Read more